Holds one active US DMF and 2 valid CEPs for trimethoprim, filing since 2012. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 19 markets.
Holds one active US DMF and 2 valid CEPs for trimethoprim, filing since 2012. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 19 markets.
Holds one active US DMF and one valid CEP for trimethoprim, filing since 2011. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Holds one active US DMF for trimethoprim, filing since 2001. Its 2018 FDA inspection closed as NAI.
Holds 2 active US DMFs for trimethoprim, filing since 1998. Its GMP is recognised in 5 markets.
Holds one active US DMF for trimethoprim, filing since 2018. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds one active US DMF for trimethoprim, filing since 2014.
Holds one active US DMF for trimethoprim, filing since 1987.
Registered with DAV (Vietnam) for trimethoprim. Its GMP is recognised in 1 market.
Registered with DAV (Vietnam) for trimethoprim. Its GMP is recognised in 1 market.
Registered with DAV (Vietnam) for trimethoprim. Its GMP is recognised in 1 market.
Registered with DAV (Vietnam) for trimethoprim.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
Contract manufacturers make to order rather than holding their own filing for this molecule.
The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free| Year | Median | Exporters |
|---|---|---|
| 2026 YTD | $21.98 | 29 |
| 2025 | $22.79 | 58 |
| 2024 | $23.00 | 46 |
| 2023 | $23.50 | 56 |
US dollars per kilogram, customs export unit values.